Full-Length spp24, but Not Its 18.5-kDa Proteolytic Fragment, Inhibits Bone-Healing in a Rodent Model of Spine Fusion

Sintuu, Chananit; Simon, Robert J.; Miyazaki, Masashi; Morishita, Yuichiro; Hymanson, Henry J.; Taghavi, Cyrus; Brochmann, Elsa J.; Murray, Samuel S.; Wang, Jeffrey C.
June 2011
Journal of Bone & Joint Surgery, American Volume;6/1/2011, Vol. 93-A Issue 11, p1022
Academic Journal
Background: Growth factors like bone morphogenetic protein (BMP) are used as bone-graft substitutes to enhance bone growth in clinical situations. However, adverse reactions have been associated with BMP use. We developed a synthetic adjuvant therapy based on the sequence of a BMP-binding protein, secreted phosphoprotein-24 (spp24), which enhances the effects of BMP5 and ameliorates the adverse reactions. Our hypothesis is that a natural proteolytic fragment of spp24 is identical to an osteogenic protein previously described independently by two investigators. To test this hypothesis, spp24 and a truncated form of spp24 were separately implanted with recombinant human BMP-2 (rhBMP-2) in a rodent model of spine fusion. Methods: Two isoforms of spp24 were constructed with use of DNA recombinant technology. Spp24 with or without rhBMP-2 were added to collagen sponges and implanted bilaterally between L4 and L5 transverse processes Radio- graphs were made biweekly, and spines were explanted after eight weeks. Gross evaluation, microquantitative computed tomography study, and histological analysis were performed to evaluate bone growth. Results: Animals that received full-length spp24 and rhBMP-2 exhibited a complete obliteration of bone growth, while animals with the truncated form in combination with rhBMP-2 exhibited a mild inhibition to bone growth, with bone area measured from radiographs. Manual assessment and gross evaluation of all spines confirmed the results obtained from the bone-area measurements. Microquantitative computed tomography provided three-dimensional visual images of representative specimens, while histological staining of spine tissue displayed cellular evidence of bone formation. Conclusions: Results from this investigation confirm that the various isoforms of spp24 affect the bone-healing activity of rhBMP-2 in the rat spine fusion model. Thus, proteolytic modification of this protein is a likely mechanism for the regulation of BMP availability in the physiological environment. Future studies will define the roles of these proteins in controlling the activity of BMP5 and other members of the transforming growth factor-beta family of cytokines. This information will increase the understanding of normal bone-healing, allowing for the engineering of more effective orthopaedic treatment.


Related Articles

  • Osteogenic Protein-1: A Review of its Utility in Spinal Applications. Brown, Andrew; Stock, Gordon; Patel, Alpesh A.; Okafor, Chukwuka; Vaccaro, Alexander // BioDrugs;2006, Vol. 20 Issue 4, p243 

    The potentially revolutionary effect that bone morphogenic proteins (BMPs) could have on orthopaedic surgery has fueled an exhaustive research effort that continues today. Upwards of 1.5 million bone-grafting operations take place in the US annually, with the anterior and posterior iliac crest...

  • Biological effects of rinsing morsellised bone grafts before and after impaction. Gerjon Hannink; Ester Piek; Jose Hendriks; Peter Van der Kraan; B. Schreurs; Pieter Buma // International Orthopaedics;Jun2009, Vol. 33 Issue 3, p861 

    Abstract  Rinsing bone grafts before or both before and after impaction might have different effects on the incorporation of the graft. Rinsing again after impaction might negatively influence bone induction if growth factors released by impaction are washed away. We studied if...

  • Growth factors in orthopaedic surgery: demineralized bone matrix versus recombinant bone morphogenetic proteins. Hinsenkamp, Maurice; Collard, Jean-Francois // International Orthopaedics;Jan2015, Vol. 39 Issue 1, p137 

    During recent decades the utilisation of growth factors, especially BMPs, has received an increasing interest in orthopaedic surgery. For clinical implantation the two main options are demineralised bone matrix (DBM) and recombinant bone morphogenetic proteins (rhBMP). Many clinical studies...

  • Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on titanium with surface-grafted chitosan and immobilized bone morphogenetic protein-2. Tee Yong Lim; Wang, W.; Zhilong Shi; Chye Khoon Poh; Neoh, K. G. // Journal of Materials Science: Materials in Medicine;Jan2009, Vol. 20 Issue 1, p1 

    Circulating progenitor cells are known to home to various organs to repair injured tissues or to routinely replace old cells and maintain tissue integrity. Similarly, circulating progenitor bone cells can possibly home to a bone implant, differentiate, and eventually osteointegrate with the...

  • Overview of Radiology, Histology, and Bone Morphogenetic Protein Expression during Distraction Osteogenesis of the Mandible. Campisi, Paolo; Hamdy, R.C.; Lauzier, D.; Amako, M.; Schloss, M.D.; Lessard, M.L. // Journal of Otolaryngology;Sep/Oct2002, Vol. 31 Issue 5, p281 

    Introduction: Distraction osteogenesis (DO) is a form of in vivo tissue engineering during which an osteotomy and controlled distraction are used to lengthen bone. The molecular signals that govern distraction-induced bone formation have not been fully elucidated. Specifically, the role of bone...

  • Bone morphogenetic protein-3 is a negative regulator of bone density. Daluiski, Aaron; Engstrand, Thomas; Bahamonde, Matthew E.; Gamer, Laura W.; Agius, Eric; Stevenson, Sharon L.; Cox, Karen; Rosen, Vicki; Lyons, Karen M. // Nature Genetics;Jan2001, Vol. 27 Issue 1, p84 

    Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-β (TGF-β) superfamily. Many BMPs are produced in bone and show osteogenic activity, suggesting that they may be determinants of bone mass. BMP3 was originally purified from bone as osteogenin, which induces...

  • Bone Morphogenetic Proteins: From Basic Science to Clinical Applications. Reddi, A.H. // Journal of Bone & Joint Surgery, American Volume;Mar2001 Supplement 1 Part 1, Vol. 83-A, pS1-1 

    Discusses the role of bone matrix as a repository of bone morphogenetic proteins (BMP). Purification, cloning and expression of recombinant BMP; Chondrogenesis and cartilage maintenance; BMP family in humans and chromosome location; BMP receptors and smads; Clinical applications of BMP.

  • Bone growth material looks promising. Moore, Amy Slugg // RN;Nov99, Vol. 62 Issue 11, p96 

    Relates the potential of bone morphogenic protein for the replacement of missing bone in humans.

  • The Effect of Osteogenic Protein-1 on the Healing of Segmental Bone Defects Treated with Autograft or Allograft Bone. Salkeld, Samantha L.; Patron, Laura Popich; Barrack, Robert L.; Cook, Stephen D. // Journal of Bone & Joint Surgery, American Volume;Jun2001, Vol. 83-A Issue 6, p803 

    Background: Large amounts of bone graft are frequently used to elicit the healing of bone defects resulting from reconstructive procedures. Autograft and allograft bone are often used, but each has its limitations. Bone morphogenetic proteins (BMPs) improve the healing of segmental bone defects...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics